| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,627 |
19,572 |
$1.57M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,858 |
8,179 |
$1.02M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,844 |
12,996 |
$764K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,939 |
5,932 |
$532K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,161 |
3,162 |
$416K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
8,199 |
6,254 |
$197K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,061 |
3,055 |
$193K |
| 99051 |
|
7,196 |
6,726 |
$147K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,505 |
1,171 |
$88K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,357 |
1,717 |
$82K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,079 |
2,177 |
$61K |
| 0240U |
|
327 |
264 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
752 |
711 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
126 |
107 |
$2K |
| 87428 |
|
33 |
25 |
$1K |
| 0011A |
|
20 |
14 |
$715.00 |
| 0012A |
|
17 |
14 |
$260.00 |
| 81003 |
|
136 |
113 |
$244.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
12 |
$223.91 |
| 99000 |
|
1,401 |
1,168 |
$0.00 |
| 91301 |
|
23 |
12 |
$0.00 |
| A9150 |
Non-prescription drugs |
29 |
25 |
$0.00 |